Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China
Tuesday, September 23, 2025Idorsia Ltd announces that Simcere Pharmaceuticals Group Ltd HK Simcere has launched QUVIVIQ daridorexant in China QUVIVIQ Idorsias dual orexin receptor antagonist is indicated for the treatment
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
Friday, September 19, 2025Vertex Pharmaceuticalsannounced today a reimbursement agreement with the Italian Medicines Agency AIFA for eligible transfusiondependent beta thalassemia TDT and severe sickle cell disease SCD patients
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Thursday, September 18, 2025Biogen Incannounced that the European Commission EC has granted marketing authorization for ZURZUVAE zuranolone to treat postpartum depression PPD in adults following childbirth ZURZUVAE
Biocytogen announces that ADC innovator Tubulis has signed a worldwide exclusive license agreement for a single antibody
Thursday, September 18, 2025Biocytogen Pharmaceuticals Co Ltda global biotechnology company advancing the research and development of novel antibody therapeutics with innovative technologies today announced that ADC developer
ProBioGen to Lead GMP Manufacturing Operations at Berlin Center for Gene and Cell Therapies (BC GCT)
Wednesday, September 17, 2025ProBioGen and the Berlin Institute of Health at Charit BIH announced today that ProBioGen has been selected to operate the process development and good manufacturing practice GMP production
CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals as the global event returns to Germany
Wednesday, September 17, 2025Informa Markets will once again welcome the global pharmaceutical industry to CPHI Frankfurt running from October to at Messe Frankfurt The threeday event is expected to draw more than attendees
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Tuesday, September 16, 2025Novo Nordisk today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has approved an update to the Rybelsus oral semaglutide label
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Tuesday, September 16, 2025Basilea Pharmaceutica Ltd Allschwil a commercialstage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections announced today that the Biomedical
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
Friday, September 12, 2025Nacuity Pharmaceuticals Inc Nacuity a clinicalstage biopharmaceutical company focused on innovative treatment of ocular diseases involving oxidative stress today announced positive
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
Thursday, September 11, 2025CAMP Therapeutics Corporation Pa clinicalstage biopharmaceutical company developing a pipeline of regulatory RNAtargeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels
